- Record: found
- Abstract: not found
- Article: not found
Evaluation of outcomes in patients (pts) with stage 4 non-small cell lung cancer (NSCLC 4) harboring actionable oncogenic drivers (AOD) when treated prior to report of mutation without tyrosine kinase inhibitors (TKI): An Integra Connect Database (ICD) retrospective observational study.
Robert E. Smith, Melissa Johnson, Lucio N. Gordan, Mei Xue, Prateesh Varughese, Natalie A. Dorrow, Brandon Wang, Varun Vaidya, Mike Gart, Hinco Gierman, Jeffrey J. Scott, RE Smith, ML Johnson, LN Gordan
2022
Read this article at
ScienceOpenPublisher
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.